Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL)

Trial Profile

Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL)

Phase of Trial: Phase III

Latest Information Update: 12 Jan 2018

At a glance

  • Drugs Udenafil (Primary)
  • Indications Congenital heart defects; Ventricular dysfunction
  • Focus Registrational; Therapeutic Use
  • Acronyms FUEL
  • Sponsors Mezzion
  • Most Recent Events

    • 24 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Jul 2018.
    • 24 Aug 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Jul 2018.
    • 25 Jul 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top